Bio-Rad Laboratories Class B
BIO.B
5 hedge funds and large institutions have $4.16M invested in Bio-Rad Laboratories Class B in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
2% more capital invested
Capital invested by funds: $4.07M → $4.16M (+$86K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0.59% → 0.59% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$23.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$553 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $3.08M | – | – | – |
|
2
Dimensional Fund Advisors
Austin,
Texas
| $901K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $137K | – | – | – |
|
|
4
Barclays
London,
United Kingdom
| $39K | +$23.1K | +167 | +140% |
|
|
5
Citigroup
New York
| – | -$553 | -4 | -67% |
|
BIO.B Hedge Fund Activity: Q4 2015 in Review
5 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q4 2015, worth a combined $4.16M — up 2.1% from $4.07M a quarter earlier.
Fund positioning in BIO.B was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Barclays, adding an estimated $23.1K. The largest seller was Citigroup, cutting an estimated $553.
- 5 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $4.16M of Bio-Rad Laboratories Class B stock for Q4 2015, up 2.1% quarter-over-quarter.
- 0 funds opened new Bio-Rad Laboratories Class B positions in Q4 2015 and 0 closed out.
- The largest Bio-Rad Laboratories Class B buyer in Q4 2015 was Barclays, an estimated $23.1K added.
- The largest Bio-Rad Laboratories Class B seller in Q4 2015 was Citigroup, an estimated $553 sold.
Based on aggregated 13F filings for Q4 2015.